Increased lipophilicity and subsequent cell partitioning decrease passive transcellular diffusion of novel, highly lipophilic antioxidants.

Oxidative stress is considered a cause or propagator of acute and chronic disorders of the central nervous system. Novel 2, 4-diamino-pyrrolo[2,3-d]pyrimidines are potent inhibitors of iron-dependent lipid peroxidation, are cytoprotective in cell culture models of oxidative injury, and are neuroprotective in brain injury and ischemia models. The selection of lead candidates from this series required that they reach target cells deep within brain tissue in efficacious amounts after oral dosing. A homologous series of 26 highly lipophilic pyrrolopyrimidines was examined using cultured cell monolayers to understand the structure-permeability relationship and to use this information to predict brain penetration and residence time. Pyrrolopyrimidines were shown to be a more permeable structural class of membrane-interactive antioxidants where transepithelial permeability was inversely related to lipophilicity or to cell partitioning. Pyrrole substitutions influence cell partitioning where bulky hydrophobic groups increased partitioning and decreased permeability and smaller hydrophobic groups and more hydrophilic groups, especially those capable of weak hydrogen bonding, decreased partitioning, and increased permeability. Transmonolayer diffusion for these membrane-interactive antioxidants was limited mostly by desorption from the receiver-side membrane into the buffer. Thus, in this case, these in vitro cell monolayer models do not adequately mimic the in vivo situation by underestimating in vivo bioavailability of highly lipophilic compounds unless acceptors, such as serum proteins, are added to the receiving buffer.

[1]  D. D. Perrin,et al.  pKa prediction for organic acids and bases , 1981 .

[2]  E. Doelker,et al.  Intestinal absorption kinetics of various model drugs in relation to partition coefficients , 1988 .

[3]  N. Greig Drug Delivery to the Brain by Blood-Brain Barrier Circumvention and Drug Modification , 1989 .

[4]  G. Sawada,et al.  Novel, highly lipophilic antioxidants readily diffuse across the blood-brain barrier and access intracellular sites. , 1999, The Journal of pharmacology and experimental therapeutics.

[5]  G. Lees Contributory mechanisms in the causation of neurodegenerative disorders , 1993, Neuroscience.

[6]  Y. Magata,et al.  Evaluation of N-alkyl derivatives of radioiodinated spiperone as radioligands for in vivo dopamine D2 receptor studies: effects of lipophilicity and receptor affinity on the in vivo biodistribution. , 1992, Chemical & pharmaceutical bulletin.

[7]  E. Hall,et al.  Neuroprotective effects of the novel brain‐penetrating pyrrolopyrimidine antioxidants U‐101033E and U‐104067F against post‐ischemic degeneration of nigrostriatal neurons , 1997, Journal of neuroscience research.

[8]  F. Sörgel,et al.  Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges , 1994, Journal of the Neurological Sciences.

[9]  J. Goodwin,et al.  In vitro permeability of peptidomimetic drugs : the role of polarized efflux pathways as additional barriers to absorption , 1997 .

[10]  S. Yalkowsky,et al.  A Physical Chemical Basis for the Design of Orally Active Prodrugs , 1980 .

[11]  R. Guy,et al.  An evaluation of structure-penetration relationships in percutaneous absorption. , 1992, Farmaco.

[12]  E. Hall,et al.  Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. , 1994, Advances in pharmacology.

[13]  C. Hansch,et al.  Lipophilic character and biological activity of drugs. II. The parabolic case. , 1973, Journal of pharmaceutical sciences.

[14]  R. Conradi,et al.  The relationship between peptide structure and transport across epithelial cell monolayers , 1992 .

[15]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[16]  C. Bernards,et al.  Physical and chemical properties of drug molecules governing their diffusion through the spinal meninges. , 1992, Anesthesiology.

[17]  D. Scherman,et al.  High lipophilicity decreases drug transport across intestinal epithelial cells. , 1994, The Journal of pharmacology and experimental therapeutics.

[18]  M. Kansy,et al.  Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).

[19]  E. Hall,et al.  Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. , 1995, Journal of medicinal chemistry.

[20]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[21]  E. Hall,et al.  Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models. , 1997, The Journal of pharmacology and experimental therapeutics.

[22]  Thomas J. Raub,et al.  Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. , 1993, Journal of drug targeting.